Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Dexmedetomidine Nasal Spray and Remimazolam for the Treatment of Pediatric Bronchoscopy

NCT06755996 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06755996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06755996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Dexmedetomidine Nasal Spray and Remimazolam for the Treatment of Pediatric Bronchoscopy
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 7, 2025
Completion date
August 31, 2025
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fiberoptic bronchoscopy